What to Expect from Stem Cell Treatment: The Complete Patient Journey

Before you travel: assessment comes first

A well-run process starts long before anyone books a flight. The first step should be a remote consultation and review of your medical records — imaging, relevant test results, diagnosis history, current medications and what treatments you have already tried. The purpose is to establish whether you are actually a candidate, which for some patients means being told the honest answer is no.

This is also where expectations should be set, and where a clinic reveals a great deal about itself. You should learn what specific therapy is proposed for your situation, what evidence supports it for your condition, what outcome is realistically hoped for, over what timeframe, and what the possibility of limited benefit looks like. If the treatment is investigational for your indication — as it is for many uses discussed across our blog — you should be told so plainly.

Practical preparation follows. You may be asked to pause certain medications, particularly anti-inflammatories, before treatment. Some protocols require baseline blood work. If you smoke, you will be encouraged to stop, since it impairs healing generally. And you should discuss the plan with your own physician at home — not as a formality, but because coordination is part of doing this properly. Our candidacy article covers who is and is not suitable in more detail.

Arrival and the in-person consultation

For most regenerative procedures the stay is short — commonly a few days rather than the weeks a surgical patient would need. Medellín's altitude and mild climate make it comparatively easy on arrival, and our guide for patients traveling from the United States covers flights, documentation and logistics.

The first in-person step is a consultation and physical examination, even when a remote assessment has already been done. This matters: examining a joint, testing a shoulder, or assessing gait provides information records cannot. It is also the point at which a physician can reasonably change or decline the plan, and a clinic willing to do that is behaving correctly.

Consent should be a conversation rather than a signature collected at reception. You should be told what will be administered, from what source, what the risks are, what is expected, and what happens if there is no benefit. This is a good moment to ask the sourcing and dosing questions covered in our articles on cell sources and dosage and cell counts — and to notice how readily they are answered.

The procedure day

The day is usually less dramatic than patients expect. If your protocol uses autologous cells, it begins with a harvest — a bone marrow aspiration from the iliac crest, or a small-volume liposuction from the abdomen or flank, both under local anesthetic with sedation. The material is then processed, which takes time, so there is typically a wait between harvest and administration. If your protocol uses donor cord-derived cells, there is no harvest and the day is shorter.

Administration depends on the target. A targeted injection into a joint, tendon or the tissue around a nerve should be done under image guidance — ultrasound or fluoroscopy — because precision determines whether the material reaches the intended location. An intravenous infusion is administered like any IV, typically over some tens of minutes, with monitoring during and afterward.

The active part is usually under an hour. What surrounds it — assessment, consent, preparation, processing and post-procedure observation — takes longer, and that is appropriate. Most patients walk out the same day. You may be given specific instructions about weight-bearing, activity restriction or immobilization depending on what was treated, and these are worth following precisely rather than approximately.

The first two weeks: what normal feels like

Here is the part that surprises people most: it often feels worse before it feels better. Increased soreness, swelling or stiffness for several days is common after a targeted injection, and after an IV infusion some patients report a brief flu-like feeling or fatigue. This is generally consistent with the intended mechanism — the therapy aims to provoke a repair response rather than to suppress symptoms — and it is not a sign that something has gone wrong.

What would be concerning is different: fever, spreading redness or warmth, severe or escalating pain, or drainage from the injection site. These warrant immediate contact with the clinic, because infection, while uncommon with sterile technique, is the main procedural risk and needs prompt attention. A responsible clinic gives you a clear way to reach a physician after you leave, including once you are home.

Most protocols advise avoiding anti-inflammatory medication — NSAIDs such as ibuprofen and naproxen — for a period afterward, on the reasoning that suppressing inflammation may work against the intended healing response. This surprises patients and is worth planning around: discuss with the clinic what you can take for discomfort. Relative rest for a few days is typical, followed by graded return to activity rather than either immobility or a sudden return to normal loading.

Weeks to months: the realistic timeline

Set your expectations to a slow, gradual curve. Meaningful change, where it occurs, is typically described over six weeks to six months, and often arrives as a slow reduction in pain and a slow increase in what you can do rather than a single moment of relief. Patients who expect to feel transformed within days are frequently disappointed at two weeks, which is exactly when the process is still in its early phase.

Some people notice functional gains before they notice pain reduction — walking further, sleeping through the night, tolerating an activity they had given up. Others plateau at partial improvement. And a minority see little or no benefit, which is a real outcome that should have been discussed before payment rather than after.

What you do during this period matters enormously, particularly for musculoskeletal treatment. Structured rehabilitation is not an optional extra; across the literature, biologic therapy paired with a progressive loading program consistently outperforms the injection alone. If you were treated for a shoulder, a tendon or a joint, arrange physiotherapy at home before you travel. Our articles on tendon healing and knee osteoarthritis both make this point because it is the most common avoidable reason for a disappointing result.

Follow-up, honest assessment and what comes next

Good follow-up is a marker of a serious clinic. You should have scheduled contact points, a way to reach a physician with concerns, and an agreed way of assessing whether the treatment helped — ideally something more objective than a general impression, such as a pain and function score recorded before treatment and repeated afterward. Measuring properly protects you from both false disappointment and false reassurance.

At the assessment point, there are three honest possibilities. The treatment helped meaningfully, in which case the discussion turns to maintaining gains through continued rehabilitation and activity. It helped partially, in which case a second treatment may be reasonable — but that decision should be based on your response, not on a package you prepaid. Or it did not help, in which case a responsible clinic says so and helps you consider other options rather than selling another round.

That last scenario is the real test of a provider. At HealthBridge, our medical director Dra. Olga González leads the longevity and regenerative program, all therapies are administered by licensed physicians under Colombian regulations after individualized assessment, and we would rather tell a patient that a treatment did not work and discuss alternatives than keep selling. If you are still researching, our pillar guide to stem cell therapy in Colombia covers the science, our cost guide covers pricing, and our safety guide covers how to evaluate any clinic, including this one.